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ADVANCING HEALTH CARE 
Volunteers are needed for a National Lung Screening Trial to 
compare the effectiveness of spiral computed tomography 
(CT) scans and chest X rays in detecting lung cancer. David 
Gierada, MD, assistant professor of radiology, is principal investi- 
gator for this two-year clinical trial, which is sponsored by the 
National Cancer Institute and Washington University School of 
Medicine. 
If you meet the following criteria, you may be one of the 6,000 
patients eligible to participate in this important study. 
I Man or woman between the ages of 55 and 74. 
I Have a history of longtime and/or heavy cigarette smoking, 
for example 
• At least 1 pack/day for at least 30 years 
• 1 'A packs/day for at least 20 years 
• 2 packs/day for at least 15 years 
• 2 lk packs/day for at least 12 years 
• 3 packs/day for at least 10 years. 
e Currently a smoker or have quit smoking within the 
last 10 years. 
i Have NOT been diagnosed with lung cancer. 
i NOT undergoing treatment for any cancer other than 
non-melanoma skin cancer. 
K Have NOT had any portion of your lung removed. 
■ Not participating in a cancer prevention trial, other than a 
smoking cessation program. 
■ Not participating in another cancer screening trial, 
including PLCO. 
Participants will receive 3 annual screening exams (either 
spiral CT or chest X ray). There is no charge for the exams. 
Validated parking is available for each visit. 
Call the Volunteer for Health Office at (314) 362-1000 









Cochlear implants have restored hearing 
for thousands of patients, but no technol- 
ogy has been available to image the 
implant's insertion depth—which deter- 
mines the extent of hearing gained. 
Researchers at MIR and in the Department 
of Otolaryngology now are using computed 
tomography and new imaging techniques 
to expand sound. 
WHEN BREAST CANCER RECURS 
Hyperthermia is a decades-old treatment for many types 
of malignant tumors. Clinicians and physicists in the 
Department of Radiation Oncology are now investigating 
the benefits of using hyperthermia and radiation simulta- 
neously to treat patients with recurrent breast cancer. 
A VISION FOR THE FUTURE: MOLECULAR IMAGING  
In the postgenomic future, most anatomic disease may 
no longer exist as a result of early detection at the mole- 
cular level. And Mallinckrodt Institute will be in the 
forefront of this future medical care thanks to its Molec- 
ular Imaging Center now being established at MIR. 
RADIOLOGY AT THE WINTER OLYMPICS 
EMERGENCY AND TRAUMA CENTER: 
A CONVENIENT, MORE PRIVATE FACILITY 
With more than 2,500 participating athletes, the 2002 
Winter Olympics in Salt Lake City was the largest of the 
winter games ever held. A Mallinckrodt Institute radiolo- 
gist was on staff at the Olympic Polyclinic, providing 
health care for athletes from 77 countries. 
More than 80,000 patients annually receive emergency or 
trauma care at Washington University Medical Center. 
The new Charles F. Knight Emergency and Trauma 
Center can provide urgent, emergent, and trauma/critical 
care as well as observation in one convenient location. 
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ON THE COVER Researchers Bruce Whiting, PhD, and Margaret Skinner, PhD, are using 
the Somatom Plus 4 Volume Zoom computed tomography (CT) scanner in their cochlear 
implant study. This machine has multirow detectors that help produce high-resolution 
scans. Photograph by Tim Parker. 
>TNEWS 
Picus elected 
to FPP Board 
Daniel Picus, MD, profes- 
sor of radiology and of 
surgery and director of the 
Division of Diagnostic Radiol- 
ogy, was elected in January to 
a three-year term on the 
Washington University School 
of Medicine (WUSM) Faculty 
Practice Plan (FPP) Board of 
Directors. He is one of six fac- 
ulty-at-large representatives 
on the Board, all of whom are 
selected based on ballots sub- 
mitted by the WUSM full-time 
clinical faculty. 
The FPP was estab- 
lished in 1997 to manage the 
medical school's clinical 
operations, with responsibil- 
ity in the areas of clinical 
oversight, administration, fis- 
cal management, and clinical 
planning. Marilyn Siegel, 
MD, professor of radiology 
and of pediatrics, was one of 
the first faculty representa- 
tives on a then-13 member 
Board. She was appointed to 
an initial two-year term and 
asked to remain for an addi- 
tional three-year term, which 
was completed in January 
2002. The FPP Board is now 
comprised of 30 members 
and includes the heads of 
WUSM's clinical depart- 
ments. Gilbert Jost, MD, pro- 
fessor of radiology and head 
of Mallinckrodt Institute, 
represents the Department 
of Radiology. 








Case Review: General 
and Vascular Ultrasound, 
written by William Middle- 
ton, MD, professor of radiol- 
ogy, is one of 14 volumes 
included in the Case Review 
series published by Mosby 
Inc. The 242-page book 
includes 211 cases that are 
divided according to com- 
plexity and range from 
gallbladder sludge to intra- 
hepatic biliary ductal dila- 
tion, from tumor thrombus of 
the renal vein and inferior 
vena cava to muscle tear and 
hematoma. The book con- 
tains 440 general and vascu- 
lar ultrasound images, 
including 84 color plates. 
Middleton selected and 
scanned cases representative 
of material typically used for 
board examinations. Cases 
are presented in a question- 
and-answer format that 
allows readers to assess 
their proficiencyin each sub- 
specialty. According to Mid- 
dleton, his goal is "to provide 
an affordable, useful, and 
enjoyable learning tool for 
sonographers, residents, and 
practicing physicians." 
The Case Review series 
cross-references Mosby's 
The Requisites™ series, for 
which Middleton coauthored 






School of Medicine students 
annually honor those faculty 
members who possess the 
attributes of an outstanding 
teacher: creativity, organiza- 
tion, knowledge, compas- 
sion, energy, and dedication. 
Mokhtar Gado, MD, profes- 
sor of radiology, was among 
those honored at the Distin- 
guished Service Teaching 
Awards ceremony held in 
January at the Eric P. New- 
man Education Center on 
the Washington University 
Medical Center campus. 
Gado came to Mallinck 
rodt Institute in 1970 as an 
instructor in radiology and 
was appointed chief of neu- 
roradiology in 1971. He was 
named professor of radiol- 
ogy in 1976. Gado stepped 
down as neuroradiology 
chief in 1991 to devote more 
time to clinical and research 
activities. He is internation- 
ally known for his studies of 
Alzheimer's disease, cere- 
brovascular disease, and 
depression. 
Gado directed the neu- 
roradiology fellowship train- 
ing program at the Institute 
from 1971 to 1998, and in 
1996, he was elected by the 
diagnostic radiology resi- 
dents as Mallinckrodt Insti- 
tute's Teacher of the Year. 
He is a fellow of the Ameri- 
can College of Radiology 
and past vice-president of 
the American Society of 
Neuroradiology. Gado has 
served as a reviewer or as an 
editorial board member for 
several medical journals. 
' 
MALLINCKRODT INSTITUTE OF RADII 
1- 
in- i 




Barbara Monsees, MD, 
professor of radiology and 
chief of breast imaging, was 
recognized by the American 
Cancer Society (ACS) as a 
national leader in the field of 
breast imaging. In March, 
Monsees was one of the 
recipients of the St. Louis 
Spirit of Health Recognition 
award, which is sponsored 
by the ACS Heritage League 
Founders and Ortho 
Biotech. 
Monsees is a nation- 
ally known advocate of the 
early detection of breast 
cancer through mammog- 
raphy and of affordable, 
accessible, high-quality 
breast imaging services. 
She recently completed a 
four-year term as chair of 
the FDA's Quality Assur- 
ance Advisory Committee 
for the National Mammog- 
raphy Quality Standards 
Act and is the current pres- 
ident of the Society of 
Breast Imaging. 
WUSM ranked 
third in nation 
The fifteenth annual sur- 
vey of graduate and profes- 
sional programs conducted 
by U. S. News & World 
Report magazine lists Wash- 
ington University School of 
Medicine in St. Louis as the 
third top-ranked medical 
school in the nation, follow- 
ing Harvard University and 
Johns Hopkins University. 
In 2001, WUSM tied with the 
University of Pennsylvania 
for fourth place. WUSM's 
physical therapy program 
retained its perennial first- 
place ranking. Other WUSM 
specialties and programs in 
the top-ten list are the AIDS 
program, occupational ther- 
apy, internal medicine, cell 
biology, the drug/alcohol 
abuse program, genetics, 
microbiology, molecular 
biology, neurosciences, 
pediatrics, women's health 
program, and pharmacology/ 
toxicology. 
The magazine's survey 
of Honor Roll hospitals 
ranked Barnes-Jewish Hospi- 
tal in a tie for seventh place 
with the University of 
Michigan Medical Center. 
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the departments of Radiology 
and Otolaryngology is helping 
to create sounds from silence 
for patients with hearing loss. 
"housands of profoundly deaf men, women, 
and children have received an implanted 
device that permits them to hear carefully spo- 
ken speech, a honking car horn, and sounds 
such as a baby's wail. Now, Bruce Whiting, 
PhD, research assistant professor of radiology, 
and his colleagues at Mallinckrodt Institute of 
Radiology (MIR) and the Department of Oto- 
laryngology at Washington University School of 
Medicine want to expand the sound experience 
of cochlear implant recipients even further. 
by   BARBRA  RODRIGUEZ 
More than 40,000 people 
worldwide, some as young as one 
year, have received a cochlear 
implant: a sound-receiving device 
and a series of electrodes 
implanted into the head that 
transfers sounds processed by a 
portable device as an electrical 
signal to the auditory nerve of the 
inner ear. Some patients have 
received a cochlear implant 
because of trauma to ear struc- 
tures, such as delicate hair cells 
that transmit sound information 
or because of complications from 
diabetes, Meniere's disease, or oto- 
sclerosis (the development of bony 
growths in the inner ear). And 
other patients, as they age, simply 
no longer benefit from the most 
powerful hearing aids. 
Using the implants, more than 
half of the patients can hear about 
80 percent of the words in record- 
ings of well-articulated, easy sen- 
tences, such as the test developed 
at Central Institute for the Deaf at 
Washington University Medical 
Center. Phone conversations or 
other sounds may still be difficult 
though, be it a whispered aside 
between friends, the comments of 
a loved one watching television in 
the next room, or a hushed pas- 
sage of a Beethoven symphony. 
Opposite page: 1) Computed tomography (CT) slice. 
2) Two-dimensional X ray of patient with cochlear 
implant. 3) Computed tomography overlay on 
two-dimensional X ray. Illustrates coregistration 
of projected CT voxels (grey) onto CR pixels (white). 
4) Two-dimensional X ray backprojected to three- 
dimensional CT image. 
Imaging roadblocks 
How deeply a hearing implant's 
thin strand of electrodes is placed 
into a patient's inner ear was 
thought to influence the extent of 
hearing ability gained. But no one 
knew for certain where each elec- 
trode was in the cochlea after 
surgery because no adequate diag- 
nostic imaging techniques existed. 
Conventional radiographs did not 
provide enough three-dimensional 
information about anatomy, while 
cross-section modalities (CT, MRI) 
blurred individual array elements. 
"The electrode insertion is done 
blind," says Margaret Skinner, PhD, 
professor of otolaryngology and 
director of the School of Medicine's 
cochlear implant program. 
In the 1990s, Skinner teamed 
up with Mallinckrodt Institute 
imaging specialists and researchers 
across the country to improve 
imaging of cochlear implants in the 
inner ear. Whiting began directing 
the current imaging project soon 
after coming to Mallinckrodt Insti- 
tute in 1997 from industrial posi- 
tions where he had worked on 
computed radiography and other 
medical imaging technology. "With 
Bruce's input, we're trying to push 
the limits of imaging technology to 
the max," Skinner says. 
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The external, middle, and inner ear. 
"\    \  \ 
The bionicear 
Components of the ear nor- 
mally turn sound waves into vibra- 
tions within fluid-filled channels of 
the spiraling, snail-shaped cochlea. 
Jutting into one channel are cells 
whose surface is dotted with hairs. 
Just as seaweed bends in response 
to a passing wave, the hairs are 
indirectly bent by the passing vibra- 
tional waves, which stimulates the 
cells to activate nearby auditory 
neurons. 





Todd Gebke, RT(R), assisted Skinner in setting up 
the cochleor implant studies. 
A cochlear-implant user wears 
an external microphone and a bat- 
tery-powered speech processor, 
which groups incoming sounds of 
similar pitches together. The packets 
of electrical sound information, or 
filter bands, are sent to a receiver 
implanted under the skin of the 
patient's skull. The receiver relays 
the signals to the electrodes 
threaded into one of the cochlea's 
channels, which excite auditory neu- 
rons lying beneath the channel wall. 
Selected pitches, or frequen- 
cies, of sound are sent to different 
electrodes because neurons along 
the cochlea's length usually 
respond to different pitches. For 
example, the vowel in the word 
"caught" is loaded with lower- 
pitched sounds that normally cre- 
ate vibrational waves further into 
the cochlea. An implant recipient 
whose electrodes only extend 
halfway into the cochlea may thus 
receive this lower-pitched informa- 
tion at the wrong neurons. 
MIR research 
To determine if insertion depth 
influences hearing ability, Whiting 
joined an imaging project initially 
begun by Kyongtae Bae, MD, PhD, 
assistant professor of radiology. 
The study involved patients who 
had a 22-electrode array implant, 
manufactured by Cochlear Corpo- 
ration, that could deliver digital 
speech information to 22 areas 
within the cochlea. 
Bae was testing the possibility 
of visualizing the implants by com- 
bining the high spatial resolution 
information of computed radiogra- 
phy (CR) with the improved 3-D 
positional information of computed 
tomography (CT). This combination 
required precise positioning of a 
patient's head so the central ray in 
the radiograph was aligned to the 
long axis of the spiral cochlea— 
which was accomplished under the 
guidance of Franz Wippold, MD, 
associate professor of radiology 
and chief of MIR's neuroradiology 
section, and with expert assistance 
from radiology technologists. CT 
scans were performed with a 
patient's head positioned so image 
slices were orthogonal to the 
cochlear axis. To align the images, 
Bae attached six metal spheres to 
each volunteer's face to identify the 
same positions on each image. 
Whiting modeled this' approach 
using computer algorithms and 
revealed that any movement of the 
reference spheres between scans 
would throw off the alignment 
process. "If the alignment was off 
by just fractions of a millimeter," 
Whiting says, "then the alignment 
could be off by centimeters when 
we mapped back to the head." 
He suggested using the irregu- 
larly shaped implant receiver and 
electrode wires as reference 
objects to provide about 50,000 
comparative points between the 
images. An algorithm to determine 
alignment transformation was 
developed, and more than a year's 
effort permitted the relative posi- 
tion of implants in the cochlear 
channel to be determined for a 
dozen patients, as reported in the 
November 2001 issue of the journal 
Radiology. "We were able to take 
these three-dimensional structures 
that were visible on the CT scan 
but not on the X ray and superim- 
pose them," Whiting says. 
The coregistered CR and CT 
information helped Skinner deter- 
mine that insertion depth mattered. 
When some electrodes could not be 
inserted into a patient's cochlea, 
the speech processor was pro- 
grammed so no sound information 
was delivered on those electrodes. 
Meanwhile, the processor sent the 
remaining, inserted electrodes mis- 
matched pitch information, or fre- 
quency bands. 
"As it turns out, frequency 
band assignment is a very impor- 
tant factor in a patient's speech 
recognition," Skinner says. "The 
better the match between the char- 
acteristic frequencies for the neu- 
rons and the bands they set, the 
faster a patient is going to learn 
and understand speech." 
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Those patients who had the full 
array inserted, for example, often 
achieved close to 100 percent word 
recognition of pre-recorded sen- 
tences. But a woman with a narrow 
cochlear canal, or other patients 
who had less than half an array 
inserted because of a short cochlea 
or disease-related channel damage, 
faired much worse. 
Other implant recipients even- 
tually achieved the 80 percent word 
recognition despite having as little 
as half of an electrode array 
inserted, suggesting, as Skinner 
notes, that mentally astute people 
with few factors to hinder sound 
recognition can mentally adapt to a 
moderate extent of pitch mismatch. 
The image coregistration 
process also allowed the investiga- 
tors to visualize when an electrode 
strand was kinked or constricted, 
which disrupted the affected elec- 
trode's function. Such information 
should allow audiologists in the 
future to improve an implant user's 
hearing by parceling out sound 
information to the remaining 
electrodes. 
In 2000, Barnes-Jewish Hospi- 
tal purchased a Somatom Plus 4 
Volume Zoom scanner, based on 
new, multirow CT technology. The 
CT scanner, manufactured by 
Siemens, has four rows of X-ray 
detectors, which permit scans to 
cover about four times more vol- 
ume in a given time. The device 
also has a high-resolution mode, 
with upwards of twice the resolv- 
ing power of previous helical scan- 
ners. Evaluations indicated the 
hearing researchers can locate indi- 
vidual electrodes that previously 
were a blur on CT scans. 
Further research 
About 20 patients who have 
newer versions of cochlear 
implants have been scanned this 
past year on the Volume Zoom 
scanner with great success. But 
Whiting, Skinner, and their col- 
leagues are not satisfied that every- 
thing has been done to improve the 
benefit of implants. Whiting is in 
the third year of a grant from The 
Whitaker Foundation to enhance 
the Volume Zoom imaging informa- 
tion even further. In part, the work 
involves constructing mathematical 
models that predict the physics of 
CT data acquisition. The goal: 
removing imaging artifacts created 
by radiodense electrodes and other 
metal implant components. 
These components produce 
stark white regions on CT images 
that obliterate underlying details in 
the same way that sunlight 
reflected into a rearview mirror 
masks part of the image. Whiting is 
addressing the issue, using statisti- 
cal reconstruction algorithms 
developed by Washington Univer- 
sity colleagues Joseph O'Sullivan, 
PhD, professor of electrical engi- 
neering and of radiology; Donald 
Snyder, PhD, professor of electrical 
engineering and of radiology; and 
David Politte, PhD, research 
instructor in radiology. 
widespread use of 
cochlear implants 
Count Alessandro Volta, a 
pioneer in electrochemistry, 
developed the electrolytic cell 
and attempted to determine 
what effect electric current had 
on sensory systems. 
Organized studies are conducted 
to determine whether stimulation 
of the auditory nerve could result 
in the sensation of hearing in 
humans. 
Researchers observed that 
activation of the auditory nerve 
with an electrical device provided 
auditory stimulation in humans. 
This observation paved the way 
for cochlear implants. 
Cochlear implant was developed 
and tested in labs in Australia. 
Cochlear implant was developed 
and tested in the United States. 
U.S. Food and Drug Administra- 
tion approved the 3M/House 
single-channel cochlear implant 
as first device to replace a 
human sense. 
FDA approved the 22-channel 
Nucleus cochlear implant for 
use in children between the ages 
of 2 and 17. 
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g's expertise in medical imaging 
has been beneficial in evaluating 
cochlear implants. 
Bottom: Skinner and Tom Renaud, RT(R), moni- 
tor the positioning of a patient in the CT scanner. 
Specifically, Whiting has cre- 
ated a 3-D model of the ideal CT 
acquisition process—how X rays 
would pass through an implant and 
reach the Volume Zoom 
detectors with attendant dis- 
tortions. He then compares 
the implant's estimated sig- 
nal and actual signal and cor- 
rects for inconsistencies on 
the reconstructed image. 
The process works well, 
although Whiting has a few 
remaining distortions to 
remove. He also intends to 
shorten the hour-long com- 
putational process to make 
the approach more clinically 
relevant. 
The improved images 
from this 3-D modeling effort 
also have allowed the implant 
researchers to better visual- 
ize the exact position of each 
0.5-mm wide electrode within 
the cochlear channel. Using 
image registration algorithms 
developed by Barry Bruns- 
den, research engineer in 
MIR's electronic radiology 
laboratory, surgeons can now 
do preimplant and postim- 
plant imaging and learn about 
bone damage that can affect 
surgical implantation. 
The sharper images also have 
given the hearing researchers a bet- 
ter understanding of where 
implanted electrodes rest within 
the cochlear channel, which will 
aid in enhancing the implant's ben- 
efits. An electrode's position within 
the scala tympani channel of the 
cochlea influences hearing. An 
electrode resting far from the neu- 
rons requires more current, 
whereas a closer electrode requires 
less current to cause a sensation of 
hearing. A patient needs just the 
right amount of current to each 
electrode to hear sound with the 
least distortion. 
Skinner and Whiting have 
begun sending the electrode posi- 
tional information to Charles Fin- 
ley, PhD, associate professor of 
otolaryngology, at the University of 
North Carolina School of Medicine. 
Finley's estimates of the electrical 
field produced around each elec- 
trode will be used to model the 
anticipated effect on nearby audi- 
tory and other neurons. That 
knowledge will be combined with 
additional information about the 
functional status of a patient's audi- 
tory neurons. 
Altogether, the imaging infor- 
mation, electrical field monitoring, 
hearing tests, and other efforts of 
the clinicians, scientists, and engi- 
neers should permit more effective 
programming of a patient's sound 
processors. The efforts may also 
provide the informational impetus 
to convince cochlear implant man- 
ufacturers to develop more tailored 
models for patients with different 
circumstances. "The imaging effort 
is just a piece of the picture," Whit- 
ing says. "It's an important part of 
the research, but I believe there's a 
wealth of other activities that are 
going to be based on the imaging, 
which eventually will lead to better 
patient outcomes." 
Applying his computational 
background to a project that links 
technology to patient care already 
has been rewarding, Whiting adds. 
"It's very satisfying to translate 
these new technical ideas into 
something that has real life bene- 
fits," he says, ma 
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When 
ONCOLOGY 
AND  PHYSICISTS 
G A T I N G 
THE  BENEFITS 
OF  USING   HEAT 
AND   RADIATION 
TO  DESTROY 
CANCER  CELLS. 
BY  CHRIS  WAYLAND 
cancer 
WOMAN 'HO HAS HAD A MASTECTOMY FOLLOWING A DIAGNOSIS OF 
I, THE TUMOR IS GONE BUT THE RISK OF RECURRENCE 
REMAINS IF CANCEROUS CELLS ARE PRESENT IN THE CHEST WALL. HEAT- 
INDUCED RADIOSENSITIZATION IS KEY TO ATTACKING THIS NONVISIBLE CAN- 
CER, SAYS ROBERT MYERSON, PHD, MD, CLINICAL CHIEF OF HYPERTHERMIA AT 
woman 
IENT OF RADIATION ONCOLOGY. 
MYERSON IS THE PRINCIPAL INVESTI- 
GATOR FOR A NATIONAL INSTITUTES 
• HEALTH/NATIONAL INSTITUTE OF 
.NCER-FUNDED CLINICAL STUDY OF 
THE LONG-TERM EFFECTS OF SIMUL- 
TANEOUSLY TREATING RECURRENT 
BREAST CANCER WITH HEAT TREAT- 
SURLAS protoype used in laboratory studies. 
AND RADIATION 
MENTS, KNO 
ID DELfVERS THE H. 
HYPERTHERMI 
CANCER CELLS TO A TEMPERATURE OF 41°C GUST BELOW 106°F) AND MAKING 
THE CELLS MORE RECEPTIVE TO RADIATION. THE RESULT? MC CANCEROUS 
DESTROYED BY THIS DUAL THERAPY THAN WHEN RADIA 
) ALONE. THE NUMBER OF TREATMENTS GrVEN, THE TIMING OF THE 
HYPERTHERMIA, AN TECHNOLOGY >ED TO DELIVER THE TREATMENTS 
PLAY KEY ROLES IN THIS 
hyperthermia 
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Robert Myerson, PhD, MD 
"W; ' e know that mild temperatures of heat given at the same time as radiation can 
markedly enhance the ability of 
radiation to kill cancer cells. It's 
very important that the radiation 
and the heat be given at the same 
time," says Myerson. "If a patient 
receives the heat and then ten min- 
utes elapse before she is given the 
radiation treatment, the radiation 
enhancement is much, much less." 
By itself, 41°C would not kill 
any cancer cells or normal cells 
unless the temperature was main- 
tained for an extremely long time, 
Myerson says, adding that hyper- 
thermia would only be given for an 
hour. But an hour is long enough to 
interfere with the ability of the 
cells to repair themselves from the 
effects of radiation. 
Since hyperthermia is deliv- 
ered at either 41°C or 42°C, heating 
the entire target area consistently 
makes the synergistic effect with 
the radiation work best. Tempera- 
ture monitors track the heat at 
eight tol2 points on the skin of the 
chest wall, and the heat can be 
redirected through a sophisticated 
grid pattern that allows the heat to 
be turned on and off. 
"We have a huge amount of 
flexibility in the distribution of the 
heating pattern to the chest walls. 
If the patient does have discomfort 
in one part of the chest wall, we 
can selectively reduce the heating 
in that area," Myerson says. 
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The clinical study 
Each woman participating in the 
study will receive four hyperther- 
mia treatments. One area of her 
chest wall, either the lateral or mid- 
dle portion, will be heated and com- 
pared to the nonheated site. 
Radiation will be applied to the 
whole targeted area. Researchers 
will look at long-term effects such as 
tissue discoloration or scar tissue. 
"The first group of patients will 
receive four hyperthermia treat- 
ments," Myerson says. "If the late 
effects in the heated portion of the 
chest wall are not different than 
those in the nonheated portion or if 
the changes in the heated portion 
are smaller than the benefits in 
terms of attacking cancer cells, 
then we will open the second 'arm' 
of the study, and in the second arm 
the patients will receive eight 
hyperthermia treatments." 
To be eligible for this study, a 
woman must have had a tumor 
that originally was larger than two 
and one-half inches but either has 
been removed or shrunk with 
chemotherapy to an inch or less, or 
she must have four or more lymph 
nodes with cancer cells. Other cri- 
teria include a recurring cancer on 
the chest wall that has not been 
previously treated with radiation, 
and a woman must be 18 years or 
older. The study consists of two 
"arms," and each arm will include 
37 patients. To date, 11 women 
have been accepted into the study. 
In two previous studies, Myer- 
son and coinvestigators looked at 
the short-term effects of using 
hyperthermia and radiation therapy 
for women with high-risk breast 
cancer and found that the patients 
tolerated the treatments well. 
These patients' tumors were larger 
than the tumors of the women in 
the current study, so these first 
groups of women (72 total) 
received four, six, or eight hyper- 
thermia treatments. Results of 
these previous studies showed that 
the benefits of treatment with 
hyperthermia outweighed any 
adverse effects. This finding led to 
the current five-year study. 
Hyperthermia 
Hyperthermia was first used in 
the Radiation Oncology Center 
at Mallinckrodt Institute in the late 
1970s, where doctors found the 
treatment to be effective in reduc- 
ing large tumors. Treatments of 30 
minutes to 60 minutes duration had 
a palpable benefit in decreasing the 
tumors and killing cancer cells, 
according to Eduardo Moros, PhD, 
a physicist in the Department of 
Radiation Oncology. 
THIS IMPORTANT 
RESEARCH IS SUP- 
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Eduardo Moros, PhD 
"During the early eighties, 
hyperthermia became the new 
weapon against cancer, and its use 
became very widespread in the 













cal trials, and 
hyperthermia studies began under 
the auspices of the Radiation Ther- 
apy Oncology Group, a multi-insti- 
tutional cooperative organization 
comprised of major research insti- 
tutions in the United States and 
Canada. But as more clinical stud- 
ies were done, investigators discov- 
ered the benefits of hyperthermia 
were not as good as those reported 
in earlier findings. Researchers 
questioned the disparity and in the 
late 1980s began to reassess the 
treatment. 
They concluded that "it was 
more difficult to heat tumors than 
was originally expected," says 
Moros. Only tumors less than three 
centimeters were responding posi- 
tively to hyperthermia. According 
to Moros, researchers looked at 
thermometry and the devices used 
for delivering the treatment, and 
changes were made in 1991. "Basi- 
cally we scratched ninety percent 
of the clinical equipment we had 
and started over," he says. 
Simultaneous 
therapy 
Around 1993, researchers and 
clinicians decided that one 
avenue to pursue was delivering 
the hyperthermia and radiation at 
the same time. In the past, some 
patients with recurring breast can- 
cer appeared to need more radia- 
tion than their bodies could safely 
handle. "There is, of course, a limit 
to the amount of radiation that can 
be given to a patient or to a partic- 
ular volume of tissue," Moros 
explains. 
But radiation dosage could be 
maximized when used in tandem 
with hyperthermia, and this syner- 
gism resulted in more cancer cells 
being killed with each dose and 
with little or no adverse effects. 
According to Moros, the most com- 
mon adverse effect of hyperther- 
mia is blistering; burns rarely 
occur. 
Myerson realizes that 41°C 
sounds like a high temperature, but 
he reminds patients that hot tubs 
are usually set at the same temper- 
ature. Also the patient's whole 
body does not reach 41°C, just a 
small area of skin about six inches 
wide on the chest wall. "Most 
patients tolerate the heat treatment 
extremely well," he says. 
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Research and development 
In the Department of Radiation 
Oncology, the ultrasound-deliv- 
ered heat is given before and after 
the radiation therapy, with patients 
receiving both heat and radiation 
treatments in the same room from 
two separate pieces of equipment. 
Moros is principal investigator of a 
National Institutes of Health/ 
National Cancer Institute grant to 
design a new ultrasound system. 
He and Petr Novak, a research 
associate, are designing portable 
equipment that can be integrated 
into the stationary radiation-deliv- 
ery system. A lightweight model of 
the equipment is about the size of a 
laptop computer. The new equip- 
ment uses ultrasonic rays, which 
are aimed at two mirrors that move 
and direct the rays to the targeted 
area. By bouncing the rays off the 
moving mirrors, a large area can be 
covered without having to move 
the ultrasound source. Current 
equipment operates at frequencies 
of 1 MHz and 3.5 MHz, allows pene- 
tration at 8 centimeters or 3 cen- 
timeters respectively, and has no 
mechanism adjustments to the pen- 
etration area . The new equipment 
will operate at 1 MHz and 
5 MHz and will allow for adjust- 
ments by having one ray firing at 
5 MHz and one at 1 MHz. 
"The new system is like 
mixing two colors to get a color in 
between," Moros explains. 
He and Novak plan to have 
the new device completed within 
the next two years, Moros says, 
adding that commercial equipment 
has already been modified to 
achieve some of the elements 
available in the new equipment. 
Three-dimensional capabilities, 
portability, and ability to deliver 
heat simultaneously are all ele- 
ments that previously have not 
been available in one machine. 
"Hyperthermia in conjunction 
with radiation therapy was always 
considered a last resort for recur- 
ring breast cancer," Moros says. 
"But with recent advances in 
technology, patients are now 
being treated with simultaneous 
therapy before receiving standard 
radiation." EH 








Schematic cross-section of the SURLAS 
Photon or electron beam I 
Editor's note: If you are 
interested in participating in the 
Department of Radiation Oncology's 
simultaneous hyperthermia 
and radiotherapy study, call 
314-454-7226 for more information. 
SURLAS (Scanning Ultrasound Reflector 
Linear Arrays System). External beam 
radiotherapy and ultrasound hyperthermia 
can be delivered simultaneously to a 
superficial target. The applicator's dimen- 
sions (especially the height, -2.6 cm) and 
construction materials were selected to 
assure acceptable attenuation of the 
photon/electron beam. 
m 
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A VISION FOR THE FUTURE 
^^ 
Today, the field of radiology is focused on using 
_• sophisticated imaging tools—positron emission tomogra- 
phy (PET), computed tomography (CT), magnetic resonance 
imaging (MRI), ultrasound, and even digital radiography—to detect 
anatomic changes that indicate disease. In a case of suspected breast 
cancer, for example, the radiologist draws from an arsenal of diagnostic imaging 
tools to determine whether the mass is malignant, based on its density, margins, 
bulk, and blood flow. 
But in David Piwnica-Worms' vision of the postgenomic future, molecular imaging will change this 
picture, shifting the emphasis away from anatomy to specific receptors, enzymes, or genes and how 
they are expressed. To evaluate that breast mass, the physician might ask these kinds of questions: 
Is there a mutant P53 transcription factor present? Is a transporter such as MDR1 P-glycoprotein 
expressed on its surface? And what do those things reveal about its characteristics? 
BY CANDACE O'CONNOR 
"As researchers, we can envi- 
sion that twenty-five or thirty years 
from now medical practice will 
occur mainly at a genetic and mole- 
cular level, where there are certain 
biochemical signs that will be 
treated systemically with highly 
targeted, specific drugs," says 
Piwnica-Worms, professor of radi- 
ology and of molecular biology and 
pharmacology. "That means a 
large swath of anatomic disease 
may no longer exist because it is 
treated as a molecular, biochemical 
abnormality long before there is 
any anatomic change." 
Piwnica-Worms and Mallinck- 
rodt Institute of Radiology (MIR) 
have just taken a giant step toward 
that future by receiving a major 
five-year, $10.5 million grant from 
the National Cancer Institute (NCI) 
to establish a molecular imaging 
center at Washington University. 
Its goal is to bring together Wash- 
ington University investigators 
from different disciplines to apply 
molecular imaging approaches to 
various cancer-related questions. 
The grant places MIR and 
Washington University in elite com- 
pany, as one of only five medical 
facilities in the United States 
awarded these P50 center grants to 
date. Of these five, MIR is the only 
one to have three major elements: 
■ the Molecular Imaging Center 
(MIC), directed by David 
Piwnica-Worms, MD, PhD 
■ a small-animal imaging resource, 
headed by Joseph Ackerman, 
PhD, professor of chemistry and 
of radiology 
■ an isotope research resource, 
under Michael Welch, PhD, pro- 
fessor of radiology and of chem- 
istry. 
The earlier phase of the grant 
application process also attests to 
MIR's reputation. When the NCI 
announced this new program in 
1999, Piwnica-Worms applied for 
one of the nine initial P20 planning 
grants to lay the groundwork for 
the MIC. The resulting three-year, 
$1.2 million grant allowed him and 
his colleagues to begin several pilot 
projects. One involved Jeffrey Mil- 
brandt, MD, PhD, of the Depart- 
ment of Pathology, who was 
looking at patterns of gene expres- 
sion in prostate cancer models; 
another had Paul Allen, PhD, also 
of the Department of Pathology, 
studying T-cell trafficking in vivo 
in a tumor ablation model. This 
year, they were among the first 
group of centers to convert from a 
planning grant to a full center 
grant. 
Today, the MIC is composed of 
several parts. There are four major 
RO-1 research projects—running 
the gamut from basic cell biology 
to translational research to a 
molecular imaging clinical trial in 
humans—all designed to be 
multidisciplinary, with molecular 
biologists, biochemists, and imag- 
ing scientists working together. 
There are also four multidiscipli- 
nary pilot projects, which may 
eventually develop into RO-1 pro 
jects. Then there is the education 
and training piece, in which lee 
tures and seminars train people in 
molecular imaging techniques 
And supporting all of this are 
three core segments: 
■ Molecular probe, which provides 
molecular biology reagents 
tooled to apply to molecular 
imaging applications. Codirected 
by Kathryn Luker, PhD, research 
instructor in radiology. 
■ Chemistry, which provides 
chemistry expertise to deal with 
specific reagents, contrast 
agents, and radiopharmaceuti- 
cals. Codirected by Vijay 
Sharma, PhD, assistant professor 
of radiology. 
■ Image analysis, which helps 
researchers who have no imag- 
ing expertise to analyze their 
images. Codirected by Richard 
Laforest, PhD, assistant profes- 
sor of radiology. 
Altogether, the MIC involves 
some 45 to 50 researchers from 
areas as diverse as pathology, 
immunology, radiation oncology, 
radiology, molecular biology, phar- 
macology, cell biology, and chem- 
istry. And word of the Center is 
spreading quickly. "There has been 
a ground swell of interest from col- 
leagues in a wide variety of depart- 
ments," says Piwnica-Worms, 
"which shows the need for this 
approach and the recognition that 
molecular imaging represents an 
exciting, new paradigm shift." 
ULAH 
u 
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David Piwnita-Worms, MD, PhD 
THE GROWTH OF 
MOLECULAR IMAGING 
The impetus behind the MIC 
came from Piwnica-Worms, who 
has been interested for some time 
in exploring a multidisciplinary 
approach to imaging questions. 
Piwnica-Worms, whose doctoral 
work was in cell physiology, com- 
pleted a diagnostic radiology resi- 
dency at Brigham and Women's 
Hospital in Boston, where his 
group developed diagnostic radio- 
pharmaceuticals used in animal 
studies. In one study, a contrast 
agent was injected into a lab rat, 
and images were taken as the agent 
entered the animal's heart. 
"But no one was asking where 
the radiopharmaceuticals went in 
the heart cell or what the biochemi- 
cal pathways of localization were," 
he says. "The chairman of the radi- 
ology department supported my 
interest in these areas, using new 
agents. These radiopharmaceuti- 
cals ended up having some very 
interesting biochemical mecha- 
nisms, which led me to look at 
imaging problems from a biochemi- 
cal perspective." 
Piwnica-Worms came to MIR in 
1994 and set up his own lab along 
these same lines, with chemists, 
molecular biologists, and imaging 
scientists involved. At times, that 
cross-pollination has created a 
remarkable synergy. "Researchers 
have gained insight into a biologi- 
cal problem because of the chem- 
istry. Or they have planned the 
chemistry because they have biol- 
ogy in mind while addressing 
certain questions or directing the 
synthesis," he says. 
Meanwhile, molecular imaging 
took off as a field around 1998, 
when groups began describing the 
new research approach as "charac- 
terizing and measuring biological 
processes in animals and humans 
at the cellular and molecular level, 
using remote imaging detectors." 
So many researchers have since 
become interested in the field that 
they have formed the Society for 
Molecular Imaging, which has 
already established links with older 
groups such as the American 
Association of Cancer Research. 
But this approach,-though new, 
is actually a way to broaden the 
scope of an existing field: nuclear 
medicine. For instance, a critical 
nuclear medicine tool—fluoro-2- 
deoxy-D-glucose (FDG) PET imag- 
ing—already involves the 
molecular probing of a transporter 
and a specific enzyme. Another 
important tool, octreoscan recep- 
tor imaging, has long used a 
peptide-based radiopharmaceutical 
to study the expression of somato 
.tin receptors type 2 (SSR-2) 
in tumors. 
\KT 
And some of the 
taking part in the Molecular Imag- 
ing Center have been working in 
nuclear medicine for some time. 
Michael Welch, who also codirects 
MIR's Division of Radiological Sci- 
ences, was one of the first 
researchers to apply modern 
organic chemistry to the prepara- 
tion of radiopharmaceuticals used 
in medical imaging and has long 
developed radiopharmaceuticals 
that target enzymes and receptors. 
For the past decade, Piwnica- 
Worms himself has been doing 
functional imaging of the multidrug 
resistance (MDR1J P-glycoprotein 
transporter, expressed in many 
cancers. \. 
"But for a major cohort of the 
investigators, the MIC represents 
an entirely new source of funding 
and collaboration that would not 
have existed except for this initia- 
tive," says Piwnica-Worms. "And 
now that the MIC is here, a dozen 
other relationships are forming 
because of the infrastructure that 
has been built and the expertise 
that has been developed. So, in a 
major way, the Molecular Imaging 
Center has generated brand-new 
collaborations, new types of 
research." 
A PARADIGM SHIFT 
While it can still be used to 
make diagnoses, assist in therapeu- 
tic planning, and predict prognosis, 
molecular imaging represents a 
number of distinct differences over 
traditional imaging. Conventional 
radiology aligns researchers and 
even clinicians by their expertise in 
different kinds of technology, such 
as MRI or CT, but molecular imag- 
ing does not. Instead, it addresses 
basic biological questions and 
matches those questions to the 
tools that best answer them. 
f 
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It also ailows^esearchers to 
look at molecular events, but not 
just in a tissue■culturexir as an iso- 
lated specimen under amicro- 
scope. Rather, molecularimaging 
lets scientists study biochemical 
abnormalities in living organisms, 
such as transgenic or genet-deleted 
mice, at the cellular and molecular 
level. To do this, the scientists 
need imaging tools-^PET/SPECT or 
micro-PET) as well as^e rigor of 
molecular cell biology anchsio- 
chemistry to vahdtffe their riiuriqgs. 
o molecular imaging takes 
the power of molecular biology and 
marries it with the technologies of 
the imaging department and begins 
to look at biochemistry and physi- 
ology in a new way," says Piwnica- 
Worms. yS 
Another change is the shift 
away from the slow-moving 
process of developing radiophar- 
maceuticals that target a specific 
tumor receptor. Molecular imaging 
also uses "reporter genes"— 
enzymes, added to the cell, which 
are imageable reporters of underly- 
ing gene regulation. In a matter 
of months, these reporter genes 
can be added to an entire cellular 
system and then used to study 
many different biological questions 
in vivo. 
And this approach also has the 
potential to move medicine away 
from what Piwnica-Worms calls 
"group therapy," or the idea of 
"treating all patients the same with 
the same drug and the same dose 
nd hoping that twenty-five percent 
f them respond," he says. In the 
uture, physicians will be able to 
.ailor therapy to the individual. 
"Clinicians will be able to get a 
molecular signature of each person 
and then manage therapy, diag- 
nose, and guide patient manage- 
ment on an individual basis." 
THE MIC'S FUTURE 
Along with his hopes for 
molecular imaging, Piwnica- 
Worms also has goals for the 
MIC. Currently, the imaging 
center is a collaborative 
research network, not a 
physical space. Eventually, 
he would like to see it 
become a large, centralized 
laboratory facility where 
researchers could work near 
collaborators in other depart- 
ments. He would also like to see 
the MIC expand the scope of its 
mquiry beyond cancer to areas 
silsh as infectious, cardiovascu- 
lar, ahdrieurologic disease. 
For rtsw, Piwnica-Worms is 
pleased with^fche progress made, 
and he remains intrigued by the 
concept of molecularsmaging, 
including its aesthetic qttahties. 
"For seasoned investigators^ 
he says, "science is like art. 
There is beauty and creativity in I 
a well-conceived experiment or 
a beautifully done series of 
studies." 
One of the recent research 
papers from Piwnica-Worms' lab 
contains an image of a mouse 
with two tiny tumors in its axilla. 
Proteins on these tumors must 
interact to turn on a PET reporter 
gene, which makes it possible for 
scientists to image them. "These 
proteins interact and dance," says 
Piwnica-Worms, "so that we are 
able to look at them from outside 
the body. That is really exciting for 
me. I find great satisfaction in the 
rigor, the vision, and seeing it all 
happen." 
Imaging protein-protein interactions in vivo using 
microPET and reporter genes. The binding of one protein 
to another protein within cells regulates how cells divide, 
sends signals from the cell exterior to the cell interior, and 
mediates when and how cells move, grow, and die. Mole- 
cular imaging of these protein-protein interactions in vivo 
will provide a broad-based tool for researchers to integrate 
existing knowledge of protein interactions within the com- 
plex physiological context of living animals. Here, a tumor 
suppressor protein known as p53 and a viral transforming 
protein known as large T antigen (TAg), two intereacting 
proteins known to be involved in turning a normal cell into 
cancer, are each fused to different portions of a transcrip- 
tion factor. Both portions of the transcription factor are 
required to activate a PET reporter gene known as HSV1 
thymidine kinase, but only one portion can bind on its own 
to specific DNA sequences that regulate activation of the 
reporter. However, when pS3 and TAg proteins interact, 
the second factor is now properly assembled, thereby 
switching on the reporter gene. The activated reporter 
can be detected by microPET imaging of living mice 
using the positron-emitting radiopharmaceutical 
18F-FHBG. (Left) Photograph of the anterior thorax 
of a mouse with axillary xenograft tumors contain- 
ing non-interacting proteins (small arrow) and 
interacting p53-TAg proteins (large arrow). 
(Right) Coronal microPET image of the same 
mouse showing accumulation of 18F-FHBG only 
in the tumor expressing the interacting 
p53-TAg proteins (large arrow). Asterisk 
denotes radiotracer in the gallbladder. 
Intestinal activity from normal hepatobil- 
iary clearance of the radiotracer is 
observed in the lower portion of 
the image. 
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RESEARCH PROJECTS 
Bioluminescence of tumor xenografts in 
a living mouse: Firefly luciferase, the 
same gene that makes fireflies glow, 
has been transduced into human HeLa 
cervical carcinoma cells and tumors 
grown in an immunocompromised 
mouse. Substrate for the luciferase 
enzyme was injected into the mouse 
causing only the four transduced tumors 
to glow. The images are obtained in a 
special light-tight box with a sensitive 
CCD camera. Regions-of-interest can be 
demarcated on the images to quantify 
the areas of gene expression. 
The Molecular/Imaging Center includes four major RO-1 grants, which 
are directed by researchers from a wide range of disciplines. "The 
Cen :er provides a vehicle for researchers with diverse expertise to 
6gether to design novel, multidisciplinary strategies that answer 
important biological questions," says Jeffrey Milbrandt, MD, PhD, 
fessor of pathology and medicine. 
He and Gary Luker, MD, instructor in radiology, are developing a sys- 
tem to detect the activity of a specific pathway in living animals. 
Eventually, this may let physicians monitor the growth of tumor cells 
in vivo, along with the human response to chemotherapeutic agents. 
Molecular imaging is exciting, says Milbrandt, because it enables him 
to track the activity of a single gene in order to determine how tumor 
progression is affected by the integrated biology of a living system. 
"This will hopefully enable me to understand how molecular 
changes result in malignant transformation," he says. 
In his project, Paul Allen, MD, professor of pathology, is continuing 
his pilot project research into T-cell trafficking in an immunotherapy 
tumor ablation model. And Lee Ratner, MD, PhD, professor of med- 
icine and of molecular microbiology, is focusing on two human 
pathogens associated with tumors-human immunodeficiency 
virus (HIV) and human T-cell lymphoma/leukemia virus (HTLV)- 
with a goal of imaging virus-infected cells in vivo. "Our research 
group's interest is in examining the efficacy of antiviral therapies in 
many different tissues of infected individuals," he says. 
Finally, David Piwnica-Worms, MD, PhD, is collaborating with med- 
ical oncologist Ramaswamy Govindan, MD, instructor in medicine; 
radiologist Farrokh Dehdashti, MD, associate professor of radiology; 
and chemist Michael Welch, PhD, professor of radiology and of 
chemistry, in a clinical trial of molecular imaging. Patients with 
advanced, small-cell lung cancer will have a technetium-94m-ses- 
tamibi scan shortly before therapy, then the researchers will observe 
the patients over time to see how the imaging predicts their outcome 
and the occurrence of multidrug resistance (MDR), a much-feared cause 
of chemotherapy failure in several forms of cancer. 
"Our goal is to know early on that a patient is likely to become multidrug 
resistant," says Piwnica-Worms. "With this information, a physician 
could alter the patient's therapy; and, since patients who present with 
MDR tend to have a more aggressive course of disease, the physician 
could also have some prognostic information." EM 
Editor's note: A listing of key faculty for the Molecular Imaging Center 
was announced in the "Spot News" section of the fall/winter 2001 
Focal Spot magazine. 
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F- 
RADIOLOGY AT THE Winter Olympics 
The nineteenth Winter 
Olympics had all the ingredi- 
ents of a sports fan's dream: 
drama (accusations of rules 
violations, unfair judging, 
and drug use), memorable perfor- 
mances (from dark-horse Sarah 
Hughes' spectacular figure-skating 
performance to Jim Shea's bitter- 
sweet victory in the skeleton 
event), wins (more gold medals 
won by the United States in 2002 
than in any other Winter 
Olympics), and a rousing flourish 
of Americana in the closing cere- 
mony (including singers Bon Jovi, 
Willie Nelson, and Gloria Estefan). 
William Middleton, MD, profes- 
sor of radiology, was among those 
fans attending the 2002 Winter 
Olympics in Salt Lake City, Utah, 
in February. He was not there as a 
spectator but as an official member 
of the Olympics medical team. 
Nationally known for his expertise 
in musculoskeletal ultrasound, 
Middleton was one of eight radiolo- 
gists from the United States' top 
medical centers invited to staff the 
Olympic Polyclinic and provide 
health care for the athletes, 
coaches, and trainers. 
"It was personally very gratify- 
ing to be invited, but I was espe- 
cially pleased that the organizing 
committee responsible for the 
Polyclinic recognized the contribu- 
tion ultrasound could make to 
these athletes," says Middleton. 
For an athlete, a quick diagno- 
sis of an injury could mean the 
difference between returning to 
competition or being forced to 
withdraw. The Polyclinic staff diag- 
nosed and treated common, sports- 
related injuries as well as more 
chronic injuries for the 2,500-plus 
athletes representing 77 countries. 
Cases ranged from a German bob- 
sledder's torn plantar fascia (the 
fibrous sheet of tissue on the sole 
of the foot) to a Canadian skier's 
patellar tendonitis to a Caribbean 
bobsledder's scrapes and cuts. 
Middleton also saw cases of exist- 
ing medical problems such as 
kidney stones and gallstones. 
Downhill skier with right knee pain. The ultrasound 
shows thickening and distortion of the right (RT) 
patellar tendon (cursors) typical of patellar tendonitis. 
The normal left (LT) patellar tendon is seen for 
comparison. 
"For the injured athlete, radiol- 
ogy was the nerve center of the 
Polyclinic. Everyone, including 
the athlete, the trainer, the 
doctor, and sometimes teammates, 
congregated in our reading room 
to see how serious the injury was," 
says Middleton. "The athletes' 
decision whether or not to return 
to competition frequently hinged 
on the results of their scans." 
The clinic was open from 8 in 
the morning until 11 in the evening 
each day and was always staffed by 
one or two radiologists. The facility 
was equipped with digital health- 
imaging equipment, including a 
mobile magnetic resonance scan- 
ner, an ultrasound machine, and 
X-ray equipment. Patients who 
needed computed tomography 
scans were sent to nearby 
University of Utah Health 
Sciences Center. 
Hockey player with shoulder pain. The ultrasound 
shows a defect (cursors) in the surface of the humeral 
head typical of a compression fracture (called a Hill 
Sachs deformity) that occurs with shoulder disloca- 
tion. This could not be seen on Xrays. 
^^HMH BBPIDHHW 
Above: From the ultrasound, Middleton could 
determine that this member of the Canadian 
ski team had patellar tendonitis. 
Middleton's tour of duty was 
the last week of the Olympics. A 
standard shift was eight hours, but 
Middleton says he liked to extend 
his shift to take full advantage of 
the once-in-a-lifetime experience. 
"In radiology we saw, on average, 
one patient every thirty minutes," 
he says. "Performing and interpret- 
ing the scans was the easiest part. 
Dealing with a new dictating sys- 
tem, new PACS system, new order- 
ing system, and an unfamiliar 
support staff was the tough part. 
Getting the films and reports to the 
athletes so they could take the 
records to their hometown physi- 
cians was, perhaps, the most diffi- 
cult part of all my medical 
responsibilities." 
This year was the first time 
Middleton was involved in the 
Olympics, and he says he would 
enjoy being on the medical staff for 
future games. The Winter Games 
in Turin, Italy, are only four years 
away. ES3 
OLYMPICS TRIVIA 
■ The Olympics were held in St. Louis in 1904, occurring simultaneously with the 
Louisiana Purchase Exhibition (or World's Fair). Boxing was added as an 
Olympic sport during the 1904 games. 
■ The flag flown at all Olympic games was introduced during the 1920 games in 
Antwerp, Belgium. It contained 5 interlocked rings representing the five signifi- 
cant continents. At least one of the colors in the flag—blue, yellow, black, green, 
and red—appears on the flag of every country in the world. 
■ The first Winter Olympics were held in 1924. 
■ An estimated 3.5 billion people worldwide watched the 2002 televised games. 
■ There were more than 55,000 spectators in the Rice-Eccles Olympic Stadium 
during the 2002 Winter Olympics closing ceremony. 
■ 15,000 police troops and security volunteers made this year's games one of the 
safest in Olympic history. 
■ The United States won 34 medals (10 gold, 13 silver, 11 bronze) in the 2002 
games. Germany was in first place with 35 medals; Norway was third with 
24 medals; Russia and Canada tied for fourth place with 17 medals each. 
■ Women's bobsled was introduced at the 2002 Winter Games. The U.S. team 
won a gold medal, and Vonetta Flowers, the team's pusher, was the first black 
athlete ever to win a gold medal in the Winter Games. 
■ Freestyle skier Shannon Bahrke won the United States' first medal (a silver) the 
first day of competition. 
■ Snowboarder Chris Klug won a bronze medal in the parallel giant slalom— 
just 19 months after undergoing a liver transplant. 
■ This was Brian Shimer's fifth, and last, Winter Olympics competition. Shimer 
won his first medal—a bronze medal in men's bobsled. 
■ Jimmy Shea's father and grandfather were Olympic athletes. Shea won a gold 
medal this year in skeleton. 
■ At the opening ceremony, U.S. athletes carried the tattered American flag from 
the World Trade Center. 

a convenient, more private facility by Vicki Kunkler 
February 5 not only marked the grand opening of The Charles F. Knight Emergency and Trauma 
Center but also the finalization of the Washington University Medical Center campus integration 
project begun in 1996. The emergency facility, housed in the new southwest tower at 400 South 
Kingshighway Boulevard, serves patients previously seen at three medical center emergency care 
units: Barnes-Jewish Hospital (BJH) south, the Schukar unit, and BJH north. 
The facility is divided into areas for urgent care, emergent care, trauma/critical care, and observa- 
tion—each with its own waiting areas and nursing stations. The center has a convenient, patient/ 
visitor parking garage; a covered ambulance bay; a dedicated elevator for the roof-top helipad; a 
work room for police, EMS personnel, and firefighters; and a state-of-the art radiology section. El 
FOR THE RECORD 
• More than 80,000 patients annually receive 
emergency or trauma care at Washington 
University Medical Center. 
• The Emergency and Trauma Center was 
built to exceed earthquake safety standards. 
• Biological or decontamination needs are 
served by inside and outside decontamina- 
tion units with separate septic systems. 
• The new center covers 52,000 square feet 
and has 61 beds. 
• The facility has computerized triage, track- 
ing, order entry, and documentation systems. 
• Washington University Medical Center has 
the only academic emergency medicine 
residency program in the St. Louis area. 
• BJH is the only St. Louis hospital to be accredited 
by the American College of Surgeons as a Level I 
Trauma Center. 
Below left: Christine Peterson, NID, setond-year diagnostic radiology 
resident, and David Rubin, MD, assistant professor of radiology and 
chief of musculoskeletal radiology, are shown in the reading room. 
Below middle: A spacious lobby — and friendly faces — welcome patients 
to the Emergency and Trauma Center. 
Below right: Christine Menias, MD, instructor in radiology, and Chris 
Tincher, RT(R), in the control room for the new Volume Zoom CT scanner. 
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In this section, the names of employees who are full-time 
faculty or staff or who have an appointment in the Depart- 
ment of Radiology or Department of Radiation Oncology 
are highlighted in boldface type. 
PROMOTIONS 
Walter Bosch, DSc, instruc- 
tor in radiation oncology, 
was promoted to research 
assistant professor of radia- 
tion oncology, Physics Divi- 
sion, Department of 
Radiation Oncology. 
Clifford Chao, MD, assis- 
tant professor of radiation 
oncology, was promoted to 
associate professor of radia- 
tion oncology, Clinical Divi- 
sion, Department of 
Radiation Oncology. 
Robert Drzymala, PhD, 
assistant professor of radia- 
tion oncology, was promoted 
to associate professor of 
radiation oncology, Physics 
Division, Department of 
Radiation Oncology. 
William Straube, MS, 
instructor in radiation oncol- 
ogy, was promoted to 
research assistant professor 
of radiation oncology, 
Physics Division, Depart- 
ment of Radiation Oncology. 
NEW FACULTY 
Bhargavi Patel, MD, 
visiting instructor in radiol- 
ogy, Division of Diagnostic 
Radiology, Department of 
Radiology. 
Alan Williams, MD, 
instructor in radiology, neu- 
roradiology section, Division 
of Diagnostic Radiology, 





Humberto Rosas, MD, 
assistant in radiology, 
received a medical degree 
from Duke University School 
of Medicine. He completed a 
two-year surgery internship 
at Barnes-Jewish Hospital, 
St. Louis. 
GRANTS 
Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy and of molecular biology 
and pharmacology, received 
a $1.6 million grant from the 
National Cancer Institute to 
study "Radiopharmaceuti- 
cals based on cross-bridged 
ligands." Anderson and 
Edward Wong, PhD, Univer- 
sity of New Hampshire, are 
principal investigators for 
the five-year grant. Mallinck- 
rodt Institute coinvestigators 
Senturia 
Lecture 
The Eighth Annual Hyman 
R. Senturia Lecture was 
presented on February 22. 
Rosemary Stevens, PhD, 
MPH, professor of history 
and sociology of science at 
the University of Pennsylvania, spoke on "The formal structure of specialization in 
medicine." William Reinus, MD, associate professor of radiology and coordinator of the 
Senturia Lecture, presented Stevens with a commemorative plaque. 
MALLINCKRODT INSTITUTE OF RADIOLOC 
.je Xiankai Sun, PhD, 
research associate, and Mu 
yang, MD, staff scientist. 
Consultant is Michael 
Ifelch, PhD, professor of 
radiology and of chemistry 
and codirector of the 
Division of Radiological 
Sciences. 
Robert Gropler, MD, asso- 
ciate professor of radiology, 
of medicine, and of biomed- 
ical engineering, as principal 
investigator, received a 
$1.5 million grant from the 
National Institutes of Health 
for "PET quantification of 
ayocardial substrate metab- 
olism." Coinvestigators are 
?ilar Herrero, MS, 
research scientist of 
radiology; Gary Hoffman, 
research associate; Terry 
Sharp, technical supervisor; 
Zulfia Kisrieva-Ware, MD, 
PhD, data analyst; Matthew 
Marison, research techni- 
cian, Department of Internal 
Medicine; Jun Young Kwon; 
John Holloszy, MD, profes- 
sor of medicine; Michael 
Welch, PhD, professor of 
radiology and of chemistry; 
and Samuel Klein, MD, pro- 
fessor of medicine. 
Jacob Locke, MD, instruc- 
tor in radiation oncology, as 
principal investigator, 
received a five-year National 
Institutes of Health Mentored 
Physician-Scientist Grant to 
study "Indomethacin and P38 
regulating AP-1 in heat 
shock." Locke's mentors for 
the $618,000 grant are 
Joseph Roti Roti, PhD, 
professor of radiation oncol- 
ogy and director of the Divi- 
sion of Radiation and Cancer 
Biology, and David Piwnica- 
Worms, MD, PhD, professor 
of radiology and of molecular 
biology and pharmacology. 
Dmitriy Yablonskiy, PhD, 
assistant professor of radiol- 
ogy and professor of physics, 
as principal investigator, 
received a $1.4 million grant 
from the National Institutes 
of Health/National Institute 
of Neurological Disorders 
and Stroke to study "Brain 
temperature control during 
functional activation." Coin- 
vestigators for the four-year 
grant are Marcus Raichle, 
MD, professor of radiology 
and of neurology and neuro- 
biology and codirector of the 
Division of Radiological 
Sciences; Joseph Acker- 
man, PhD, professor of 
chemistry, of medicine, 
and of radiology; Larry 
Bretthorst, PhD, research 
associate; and Charles 
Hildebolt, DDS, PhD, asso- 
ciate professor of radiology 
and adjunct associate profes- 
sor of anthropology. 
Jie Zheng, PhD, research 
assistant professor in radiol- 
ogy, as principal investiga- 
tor, received the Charles E. 
Culpeper Biomedical Pilot 
Initiative, a one-year grant 
sponsored by the Rocke- 
feller Brothers Fund, to 
study "Identification of rup- 
ture-prone coronary artery 
plaques with magnetic reso- 
nance imaging." Coinvestiga- 
tors for the $25,000 grant are 
Ruth Okamoto, PhD, Depart- 
ment of Mechanical Engi- 
neering; Haodong Xu, MD, 
Department of Pathology; 
Jeffrey Saffitz, MD, Depart- 
ment of Pathology; and 
Robert Gropler, MD, asso- 
ciate professor of radiology, 




Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy and of molecular biology 
and pharmacology, was 
appointed to the Washington 
University Medical Center's 
Continuing Review Commit- 
tee for the Human Studies 
Committee. 
Thomas Conturo, MD, 
PhD, associate professor of 
radiology and adjunct pro- 
fessor of physics and of 
biomedical engineering, was 
appointed as an ad-hoc ref- 
eree of National Institutes 
of Health/National Institute 
of Mental Health grants for 
Studies to Advance Autism 
Research and Treatment 
Program (STAART) Centers. 
Maurizio Corbetta, MD, 
associate professor of neu- 
rology and of radiology, was 
appointed to the editorial 
board of the journal Cortex. 
Dione Farria, MD, MPH, 
assistant professor of radiol- 
ogy, was appointed to the 
American Cancer Society's 
Reach to Recovery Advisory 
Board, Heartland Division. 
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ELECTIONS 
Continued from page 25 
Jacob Locke, MD, instruc- 
tor in radiation oncology, 
was appointed as the Depart- 
ment of Radiation Oncology 
representative to the Wash- 
ington University Disclosure 
Review Committee. 
Robert McKinstry, MD, 
PhD, assistant professor of 
radiology, was appointed to 
the National Institutes of 
Health Ad Hoc Study Sec- 
tion, Center for Scientific 
Review, High End Instru- 
mentation Program. 
Eduardo Moros, PhD, 
associate professor of 
radiation oncology, was 
appointed to a three-year 
term as a grant reviewer for 
the National Institutes of 
Health Center for Scientific 
Review, Radiation Study 
Section. 
Joel Perlmutter, MD, pro- 
fessor of neurology and of 
radiology, was appointed by 
the American Academy of 
Neurology as the 2002 Topic 
Chairman for Neuroimaging. 
William Powers, MD, pro- 
fessor of neurology and of 
radiology, was appointed to 
the Oversight Committee for 
the National Institute of Neu- 
rological Disorders and 
Stroke Multicenter Trial of 
Neuroprotection in Parkin- 
son Disease. He was 
appointed to the editorial 
board of The Journal of 
Cerebral Blood Flow and 
Metabolism. 
Marcus Raichle, MD, pro- 
fessor of radiology and of 
neurology and neurobiology 
and codirector of the Divi- 
sion of Radiological Sci- 
ences, is chairman-elect of 
the American Association for 
the Advancement of Science 
Section on Neuroscience. 
Marilyn Siegel, MD, pro- 
fessor of radiology and of 
pediatrics, was appointed 
chairwoman of the Refresher 
Course Committee, Pedi- 
atrics Subsection for the 
102'"t Annual Meeting of the 
American Roentgen Ray 
Society, to be held April 28 
through May 3 in Atlanta, 
Georgia. 
Anurag Singh, MD, assis- 
tant in radiation oncology, 
was elected to a two-year 
term on the Executive Board 
of the Association of Resi- 
dents in Radiation Oncology. 
HONORS/ 
AWARDS 
Jeffrey Bradley, MD, 
instructor in radiation oncol- 
ogy, served as an instructor 
for the 3D Practicum at the 
American Society for 
Therapeutic Radiology 
and Oncology Meeting in 
St. Petersburg, Florida. 
Clifford Chao, MD, associ- 
ate professor of radiation 
oncology, was a panel mem- 
ber for Operations Research 
Applied to Radiation Ther- 
apy, a National Institutes of 
Health/National Science 
Foundation Workshop held 
in Washington, DC. 
Eric Klein, MS, associate 
professor of radiation oncol- 
ogy, was named course 
director for the American 
College of Medical Physicists 
Radiation Oncology 
Refresher Course, held in 
Orlando, Florida. 
Joel Perlmutter, MD, pro- 
fessor of neurology and of 
radiology, was selected by 
The Hereditary Disease 
Foundation as a participant 
in the Venezuela Huntington 
Disease Research Project. 
He was named the external 
advisor for the Molecular 
Genetics of Early Onset Tor- 
sion Dystonia Program, 
directed by Xandra O. 
Breakefield, PhD, of the Mol- 
ecular Neurogenetics Unit at 
Massachusetts General Hos- 
pital in Boston. 
David Piwnica-Worms, 
MD, PhD, professor of radi- 
ology and of molecular biol- 
ogy and pharmacology, was 
named chairman of the 
American Association for 
Cancer Research Conference 
on Molecular Imaging in 
Cancer: Linking Biology, 
Function and Clinical Appli- 
cations In Vivo, held in 
Orlando, Florida. 
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,ECTURES/ 
'RESENTATIONS 
Jeffrey Bradley, MD, 
instructor in radiation oncol- 
ogy, as invited speaker, pre- 
sented "Biologically-targeted 
therapy for lung carcinoma: 
the impact of PET on GTV 
and conformal radiotherapy 
planning" at the Functional 
Imaging Symposium, Radia- 
tion Therapy Oncology 
Group Meeting, Tampa, 
Florida, January 31. As 
invited speaker, he pre- 
sented "Design of coopera- 
tive trials in North America" 
at the 2002 Mid-Winter Edu- 
cational Symposium of the 
Society of Nuclear Medicine, 
Scottsdale, Arizona, Febru- 
ary 9 and 10. 
Clifford Chao, MD, associ- 
ate professor of radiation 
oncology, spoke on "Tumor 
hypoxia: from molecular sig- 
nal transduction to func- 
tional imaging-guided 
therapy" at Grand Rounds, 
The University of Texas MD 
Anderson Cancer Center, 
Houston, Texas, January 23. 
He presented "Clinical indi- 
cations for IMRT;" "Planning 
IMRT treatments: clinical 
input;" "Clinical conse- 
quences of IMRT;" and 
"RTOG protocols for IMRT" 
at the Medical Technology 
Management Institute, Las 
Vegas, Nevada, February 1 
and 2. Chao presented 
"Intensity-modulated radia- 
tion therapy (IMRT): new 
treatment trends in oncol- 
ogy" at the Florida Hospital 
Cancer Institute, Orlando, 
Florida, February 21 and 22. 
Maurizio Corbetta, MD, 
associate professor of neu- 
rology and of radiology, pre- 
sented "Goal-directed and 
stimulus-driven attention in 
the human brain" at the Psy- 
chology Colloquium, Univer- 
sity of Pittsburgh, 
Pennsylvania, March 16. 
Steven Crawford, MD, 
clinical fellow, presented 
"Validation of an angio- 
graphic method for estimat- 
ing flow to distal tissue 
beds" at the 27th Annual Sci- 
entific Meeting of the Society 
of Cardiovascular and Inter- 
ventional Radiology, Balti- 
more, Maryland, April 7. 
Colin Derdeyn, MD, asso- 
ciate professor of radiology, 
as keynote lecturer, pre- 
sented "Pathophysiology of 
acute and chronic cere- 
brovascular disease" at the 
2'"1 Annual International 
Meeting of CT/MR Brain 
Perfusion, San Francisco, 
California, March 29. 
Biello 
Lecture 
On March 11, Steven 
Larson, MD, chief of 
nuclear medicine 
service at Memorial 
Sloan-Kettering Cancer Center in New York City, presented The Sixteenth Annual 
Daniel R. Biello Memorial Lecture, "Measuring tumor response with PET." Shown 
with Dr. Larson (right) is Barry Siegel, MD, professor of radiology and of medicine and 
director of the Division of Nuclear Medicine, and coordinator of the Biello Lecture. 
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LECTURES/ 
PRESENTATIONS 
Continued from page 27 
Louis Gilula, MD, profes- 
sor of radiology and of 
surgery, spoke on "Vertebro- 
plasty and metastatic dis- 
ease" at Missouri Baptist 
Hospital, St. Louis, Missouri, 
January 17. He presented 
"Imaging of distal radius 
fractures" at the Wrist Work- 
shop, sponsored by the Hand 
Therapists and Trainers 
Association, St. Louis, Mis- 
souri, March 5. Gilula spoke 
on "Introduction to vertebro- 
plasty," "Lumbar and sacral 
nerve blocks," and "Discog- 
raphy-lumbar" at the 25"' 
Annual Winter Skeletal Sym- 
posium sponsored by the 
University of Pennsylvania, 
Lake Louise, Alberta, 
Canada, March 11-15. He 
presented "Introduction to 
vertebroplasty," "Technical 
aspects of vertebroplasty," 
and "Problems in vertebro- 
plasty and how to handle 
them" at Orthopedic Radiol- 
ogy 2002, sponsored by the 
Radiology Department of 
Brigham and Women's Hos- 
pital, Boston, Massachusetts, 
March 24-26. 
Jay Heiken, MD, professor 
of radiology, chief of abdom- 
inal radiology, and cochief of 
body computed tomography, 
presented "A practical 
approach to small bowel 
obstruction" at Twentieth 
Annual Practical Radiology 
at Whistler, sponsored by the 
University of British Colum- 
bia, Whistler, British Colum- 
bia, Canada, February 3-8. 
Anil Khosla, MD, instructor 
in radiology, as invited 
speaker, presented "CNS 
manifestations of systemic 
cancer;" "Extramedullary 
cysts of spinal canal," "Diffu- 
sion weighted imaging-CNS 
applications," and "Carotid 
and vertebral artery dissec- 
tion" at INDO-US Imaging 
2001, Nizam's Institute of 
Medical Sciences, Hyder- 
abad, India, December 22 
and 23. As invited speaker, 
he presented "CNS manifes- 
tations of systemic cancer," 
"Diffusion weighted imaging 
in CNS," "Extramedullary 
cysts of spinal canal," and 
"Spinal intervention proce- 
dures" at INDO-US Imaging 
2001, Bhartiya Vidyapeeth 
Deemed University, Pune, 
India, December 25 and 26. 
Khosla spoke on "CNS mani- 
festations of systemic can- 
cer" and "CNS applications 
of diffusion imaging" at Neu- 
rology Update, organized by 
the Department of Neuro- 
surgery and the Department 
of Radiology, Khoula Hospi- 
tal, Muscat, Sultanate of 
Oman, December 27. 
Eric Klein, MS, associate 
professor of radiation oncol- 
ogy, spoke on "Clinical IMRT 
at Mallinckrodt Institute;" 
"Technology assessment of 
MLC, EDW, and IMRT;" and 
"Heterogeneity corrections 
and lung prescriptions" at 
Stony Brook University Hos- 
pital, State University of 
New York, Stony Brook, 
New York, March 6. He pre- 
sented "Heterogeneity cor- 
rections and lung 
prescriptions in radiation 
oncology" at the Florida 
American Association of 
Physicists in Medicine Meet- 
ing, Orlando, Florida, March 
15. Klein presented "Accep- 
tance, testing, and commis- 
sioning of Linacs;" "Facility 
shielding, design, and gen- 
eral radiation safety;" and 
"Special procedures: total 
body irradiation, stereotac 
radiosurgery, IMRT" at the 
American College of Medic;, 
Physicists Radiation Oncol- 
ogy Refresher Course, 
Orlando, Florida, March 24 
and 25. 
Jason Lewis, PhD, 
research instructor in radiol- 
ogy, presented "Radiophar- 
maceuticals: diagnostic and 
therapeutic applications" at 
Berlex Biosciences, San 
Francisco, California, 
December 11. 
Elizabeth McFarland, MD, 
associate professor of radiol- 
ogy, presented "CT colonog- 
raphy" at Internal Medicine 
Grand Rounds, Washington 
University School of Medi- 
cine, St. Louis, Missouri, 
March 14. 
Jeff Michalski, MD, assis- 
tant professor of radiation 
oncology and director of the 
Clinical Division, presented 
"History and evolution of 
external beam techniques. 
RTOG 9406;" "3-D conformal 
radiation therapy for 
prostate cancer;" "3-D con- 
formal radiation therapy for 
prostate cancer: techniques;" 
MALLINCKRODT INSTITUTE OF RADIOLOC I' 
nd "Prevention and man- 
agement of radiation therapy 
Complications" at the 
ikuna-o-ka-la Radiation 
cology Conference, 
hala Coast, Hawaii, Febru- 
M 12-15. He spoke on 
decent advances in the 
nanagement of prostate can- 
fcer: advances in radiother- 
apy: brachytherapy and 
External beam" at the Inter- 
national Center for 
Advanced Medical Educa- 
tion, St. Louis, Missouri, 
itarch 8. 
Jeff Miller, research assis- 
nt, spoke on "Temporal 
evolution of brain injury in 
erm newborns character- 
ized by diffusion tensor 
imaging" at the Annual Meet- 
ing of American Association 
of Neurological Surgery Sec- 
tion on Pediatric Neuro- 
surgery, New York City, New 
York, December 1. 
Carlos Perez, MD, profes- 
sor of radiation oncology 
and chairman of the Depart- 
ment of Radiation Oncology, 
presented "Radiation ther- 
apy in postradical prostatec- 
tomy rising PSA" to the 
greater St. Louis Society of 
Radiologists, St. Louis, Mis- 
souri, February 19. He 
spoke on "Cytoprotective 
agents in combined modality 
therapy in head and neck 
cancer" and "Advances in 
radiation oncology" at the 4th 
Annual Palm Beach Cancer 
Symposium, Delray Beach, 
Florida, March 22 and 23. 
Mehdi Poustchi-Amin, 
MD, clinical fellow, pre- 
sented the scientific exhibit 
"Principles, applications and 
protocols of the practical 
MRI of the body" at the 13th 
Annual Meeting of the Amer- 
ican Society of Emergency 
Radiology, Orlando, Florida, 
March 16-20. 
Barry Siegel, MD, profes- 
sor of radiology and of medi- 
cine and director of the 
Division of Nuclear Medi- 
cine, as visiting professor, 
spoke on "Oncologic FDG- 
PET: artifacts, variants, and 
benign lesions simulating 
cancer" and "Current status 
of PET in clinical practice" 
at Brown University School 
of Medicine and Rhode 
Island Hospital, Providence, 
Rhode Island, January 7. He 
presented "FDG-PET: arti- 
facts and variants" and 
"Applications of PET in 
oncology" at the 19th Annual 
Conference of the Society of 
Nuclear Medicine, Hawaii 
Chapter, Honolulu, Hawaii, 
February 16 and 17. Siegel 
presented "FDG PET: arti- 
facts and variants" at the 
2002 Mid-Winter Educa- 
tional Symposium of the 
Society of Nuclear Medi- 
cine, Scottsdale, Arizona, 
February 9 and 10. 
Marilyn Siegel, MD, 
professor of radiology and 
of pediatrics, presented 
"Ultrasonography of neona- 
tal retroperitoneal masses," 
"Neonatal intracranial hem- 
orrhage and ischemic brain 
injury," "Congenital brain 
anomalies," and "Ultrasonog- 
raphy of the neonatal liver" 
at the Snowmass 2002 Clini- 
cal Ultrasound Meeting, 
Snowmass, Colorado, 
March 4-6. 
Yuan-Chuan Tai, PhD, 
assistant professor of radiol- 
ogy, spoke on "MicroPET- 
positron emission tomogra- 
phy in molecular imaging" at 
the American Association for 
Cancer Research Special 
Conference in Cancer 
Research: Molecular Imaging 
in Cancer, Orlando, Florida, 
January 26. 
Jerold Wallis, MD, associ- 
ate professor of radiology, 
presented "Current status of 
nuclear medicine intercon- 
nectivity" at the High Coun- 
try Nuclear Medicine 
Conference, Vail, Colorado, 
March 1-6. 
Franz Wippold, MD, asso- 
ciate professor of radiology 
and chief of neuroradiology, 
as visiting professor, spoke 
on "Anatomy of the temporal 
bone" and "Lesions of the 
cerebellopontine angle" at 
Michigan State University, 
East Lansing, Michigan, 
March 11 and 12. 
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In this section ofFYI, only 
those faculty and staff 
who have Department of 
Radiology or Department 
of Radiation Oncology 
appointments are listed. 
THE AMERICAN ASSOCIA- 










The Fifth Joint Annual 
Meeting 
Dallas, Texas 
February 3-6, 2002 
DeWitte Cross, MD, mem- 
ber, Abstract Committee; 
moderator, Oral Presenta- 
tions 11-20. 
Colin Dereyn, MD, correc- 
tor, Special Course: Techni- 
cal and Pharmalogic 
Considerations in Acute 
Stroke Therapy and Intracra- 
nial Angioplasty/Stenting. 
ORAL PRESENTATIONS 
Colin Derdeyn, MD; 
Christopher Moran, MD; 
DeWitte Cross, MD; David 
Jeck, MD; Thomas Pil- 
gram, PhD; Keith Rich, 
MD; Robert Grubb, MD, 
"Procedural thrombus and 
postprocedural ischemic 
events after treatment of 
intracranial aneurysms with 
GDC." 
Colin Derdeyn, MD; David 
Jeck, MD; Christopher 
Moran, MD; DeWitte 
Cross, MD; Keith Rich, 
MD; Robert Grubb, MD, 
"Long-term outcome after 




Disease and Revascularization 
Colin Derdeyn, MD, "BC-IC 
bypass study results, contro- 
versies, new trials." 
POSTER PRESENTATION 
David Jeck, MD; DeWitte 
Cross, MD; Colin 
Derdeyn, MD; Christopher 
Moran, MD, "Carotid stent- 
ing for treatment of carotid 
dissection." 
INTERNATIONAL 
SOCIETY FOR MAGNETIC 
RESONANCE IN MEDICINE 
Diffusion MRI: Biophysical 
Issues (What Can We 
Measure?) Workshop 
Saint-Malo, France 
March 10-12, 2002 
Thomas Conturo, MD, 
PhD, chairman, "Diffusion 
and Pathophysiology" scien- 
tific session. 
ORAL PRESENTATIONS 
Nicolas Lori, graduate 
research assistant in radiol- 
ogy; Erbil Akbudak, PhD; 
Joshua Shimony, MD, 
PhD; Abraham Snyder, 
PhD, MD; Thomas Con- 
turo, MD, PhD, "Identifying 
the white matter pathways 
involved in lesions and MRI 
contrast patterns using diffu- 
sion tensor tracking." 
Nicolas Lori, graduate 
research assistant in radiol- 
ogy; Thomas Conturo, MD, 
PhD, "Diffusion time assign- 
ment and q-space formalism 
for finite-duration diffusion- 
encoding gradients: simula- 
tion of 3D random walks." 
Jeffrey Neil, MD, PhD, 
"Diffusion anistropy in the 
developing human brain." 
POSTER PRESENTATION 
Joshua Shimony, MD, 
PhD; Abraham Snyder, 
PhD, MD; Nicolas Lori, 
graduate research assistant 
in radiology; Thomas Con- 
turo, MD, PhD, "Automated 
clustering of diffusion tensor 
track data into neuronal 
pathways." 




Twenty-fifth Annual Course 
Charleston, South Carolina 
March 18-22, 2002 
Stuart Sagel, MD, modera- 
tor, Thoracic Imaging. 
Marilyn Siegel, MD, mod- 
erator, Pediatric Imaging. 
CUM LAUDE SCIENTIFIC PRE- 
SENTATION AWARDS 
Kyongtae Bae, MD, PhD; 
Jay Heiken, MD; Huy 
Tran, MD, "Uniform vascu- 
lar contrast enhancement 
and reduced contrast volume 
achieved by multiphasic 
injection method: clinical 
validation." 
Sanjeev Bhalla, MD; Eliz 
beth McFarland, MD; 
Ronan McDermott, MD; 
Christine Menias, MD; 
Amy Hara, MD; Adolf 
Huette, MD; Thomas 
Pilgram, PhD, "Prospective 
MDCT study of CT 
colonography compared 
to colonoscopy: diagnostic 
performance of experienced 
and recently trained 
readers." 
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Elizabeth McFarland, MD; 
Kirk Smith, senior research 
; engineer; Jeffrey Marsh, 
MD; Thomas Pilgram, 
PhD, "MR evaluation of sta- 
; ic and dynamic relation- 
ships of the velopharynx 
during speech in controls 
and cleft palate pediatric 
subjects." 
AORKSHOPI 
^F'ongtae Bae, MD, PhD, 
iging coronary arteries 
w^i multislice CT." 
: 




Stuart Sagel, MD, "CT of 







y Heiken, MD, "Liver 
l ion characterization with 
CT and MR: a practical 
proach." 
INTERACTIVE CASE SESSION 




ay Heiken, MD, "Imaging 
ncreatic carcinoma with 
L and MR." 
PEDIATRIC IMAGING 
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Stuart Sagel, MD, "CT of 
the pericardium." 
IN MEMORIAM 
It is with profound sad- 
ness that we report the 
death of Juan M. Taveras, 
MD, the third director of 
Mallinckrodt Institute of 
Radiology. Taveras, 82, died 
in his native Dominican 
Republic on March 28 from 
leukemia. 
Taveras was one of the 
world's leading neuroradiolo- 
gists, and under his leader- 
ship the Institute became a 
major center for neuroradio- 
logical research and clinical 
studies. During his director- 
ship, the Institute underwent 
a tremendous expansion in 
organization and the physical 
plant, including further orga- 
nization of the subspecialty 
system (begun by Hugh Wil- 
son, MD, second director of 
MIR), funding for the addi- 
tion of four new laboratories 
and five shell floors, and con- 
struction of Scarpellino 
Auditorium. 
Taveras came to MIR in 1964 
from the Neuroradiological 
Institute, Columbia Presby- 
terian Medical Center, in 
New York. After his depar- 
ture from Mallinckrodt Insti- 
tute in 1971, he was named 
radiologist-in-chief at Massa- 
chusetts General Hospital in 
Boston and professor of radi- 
ology at Harvard University. 
He became professor of radi- 
ology emeritus in 1988 and, 
in 1989, Harvard created the 
Juan M. Taveras Professor- 
ship. 
He returned to the Domini- 
can Republic to establish 
and direct the Centra de 
Diagnostico, Medicina Avan- 
zada, Laboratorio y Telemed- 
icina, at the Plaza de la Salud 
in Santo Domingo. Accord- 
ing to The Santo Domingo 
News, "it is likely the Plaza 
de la Salud will be renamed 
in his honor." 
Taveras was often honored 
for his medical expertise and 
received a Gold Medal 
Award from the Radiological 
Society of North America 
(1980), the Association of 
University Radiologists 
(1985), the American College 
of Radiology (1985), the 
American Roentgen Ray 
Society Society (1988), and 
the American Society of 
Neuroradiology (1995). He 
was a fellow of the Ameri- 
can Heart Association 
(Stroke Council) and of the 
American College of Radiol- 
ogy and was the founding 
editor of the American 
Journal of Neuroradiology. 
He is survived by his wife 
Mariana and his sons, and 
stepsons. Memorial dona- 
tions may be sent to the 
Centro de Diagnostico in 
Santo Domingo. 103 
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We sadly report the 
death of William 
Powers, MD, former 
director of MIR's Radiation 
Oncology Center, who died 
in Sarasota, Florida, on 
November 17, 2001, from 
cancer. He was 79. 
Powers was a recognized 
authority in treatment tech- 
niques for carcinoma of the 
uterine cervix and in preop- 
erative radiation therapy for 
head and neck tumors. Dur- 
ing his tenure at MIR, Pow- 
ers played a key role in 
radiation oncology break- 
throughs, including the 
development of the Cer- 
robend blocking system to 
protect healthy tissue while 
high doses of irradiation are 
delivered to tumors and the 
design and development of 
high-energy linear accelera- 
tors. He and MIR cancer 
biologist Leonard Tolmach, 
PhD, first proved the exis- 
tence of hypoxic cells in 
tumors. 
Powers came to Mallinckrodt 
Institute in 1952 as a diagnos- 
tic radiology resident and 
joined the faculty in 1955 as 
an instructor in radiology. He 
served as director of the 
Radiation Oncology Center 
from 1965 to 1975, taking a 
one-year sabbatical (Septem- 
ber 1969 through August 
1970) to work with the 
National Cancer Institute, as 
chief of Radiation Oncology, 
Extramural Branch, on devel- 
oping radiation therapy cen- 
ters in the United States. He 
left MIR in 1975 and was a 
visiting professor at the Uni- 
versity of Missouri, Colum- 
bia, and at the Thomas 
Jefferson College of 
Medicine in Philadelphia. 
In 1978 he once again yielded 
to the lure of academic 
administration and accepted 
the dual position of chairman 
of the Department of Radia- 
tion Oncology at Wayne State 
University and chief of radia- 
tion oncology at Harper Hos- 
pital in Detroit, Michigan, 
where he remained until 
his retirement in 1997. 
Powers received Gold Medal 
awards from the American 
College of Radiology and 
from the American Society 
of Therapeutic Radiology 
and Oncology. He was a 
member of the President's 
National Cancer Advisory 
Board. 
He is survived by his wife 
Linnea and five children. 
Memorial donations may be 
sent to the Department of 
Radiation Oncology at Wash- 
ington University School of 
Medicine in St. Louis. EH3 
Following the 1994 Probstei 
Lecture, Carlos Perez, MD, then-direc- 
tor of MIR's Radiation Oncoloi ■ 
ter, presided at the unveiling o 
official William Powers portrait, wi 
is currently displayed in the radi" 
oncology conference room on th< 
floor of the Institute. Bill and Lit, 
Powers are shown with the portrai 
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To Our Physician Colleagues 
The Clinical Positron Emission Tomography (PET) Center on the 
seventh floor of Mallinckrodt Institute of Radiology at Washington 
University Medical Center is one of the Midwest's leading PET imaging 
centers, offering comprehensive diagnostic testing for patient care. The 
center has two PET scanners and is staffed by Mallinckrodt Institute 
nuclear medicine physicians, who collectively have more than 145 years 
of experience in nuclear medicine and PET. 
Opened in 1988, the Clinical PET Center was one of the first facilities 
worldwide to make the transition from research to medical practice and 
now performs more than 20,000 nuclear medicine exams and over 2,100 
PET procedures annually. Our PET specialists are full-time clinical 
physicians of the Washington University School of Medicine and are 
on staff at Barnes-Jewish and St. Louis Children's hospitals. 
More information about PET imaging and scheduling can be accessed 
online at http://gamma.wustl.edu/division/clinical-information.html 
Call (314) 362-7418 to schedule PET examinations for your patients. 
B Washington 
University in StLouis 
SCHOOL OF MEDICINE 
Mm Mallinckrodt Institute of Radiology 
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